Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587
PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11
Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study - A randomized controlled trial
Furlan AJ, Higashida RT, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study - a randomized controlled trial. JAMA 1999;282:2003-2011
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial
Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605
Thrombolytic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome
Brandt T, von Kummer R, Mueller-Kueppers M, et al. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996;27:875-881
The Thrombolysis in Myocardial Infarction (TIMI) Trials: The first decade
Cannon C, Braunwald E, McCabe C, et al. The Thrombolysis in Myocardial Infarction (TIMI) Trials: the first decade. J Intervent Cardiology, 1995;8:117-135